Table 1.
Cohort demographic and clinical characteristics
| Characteristic | Value |
|---|---|
| Number of patients | 1316 |
| Female | 582 (44.2) |
| Age at start of PD (yr) | 67.5 (11.8)a |
| Age at death (yr) | 70.4 (11.7)a |
| Time on PD (yr) | 2.3 (1.4–3.9)b |
| State of residence | |
| New South Wales and Australian Capital Territory | 556 (42.2) |
| Victoria | 234 (17.8) |
| Western Australia | 125 (9.5) |
| Queensland | 271 (20.6) |
| Tasmania | 21 (1.6) |
| South Australia | 88 (6.7) |
| Northern Territory | 21 (1.6) |
| Region of residence | |
| major city | 720 (54.7) |
| regional | 345 (26.2) |
| remote | 69 (5.3) |
| unknown | 182 (13.8) |
| Ethnicity | |
| Caucasian | 1023 (77.8) |
| Asian | 141 (10.7) |
| Pacific | 34 (2.6) |
| Aboriginal and Torres Strait Islander | 117 (8.9) |
| Cause of death | |
| peritonitis | 78 (5.9) |
| other infection | 115 (8.7) |
| cardiac | 578 (43.9) |
| cerebrovascular | 107 (8.1) |
| peripheral vascular | 48 (3.6) |
| malignancy | 96 (7.3) |
| withdrawal | 174 (13.2) |
| other | 120 (9.1) |
| Number of peritonitis episodes | |
| 0 | 584 (44.4) |
| 1 | 380 (28.9) |
| 2 | 170 (12.9) |
| ≥3 | 182 (13.8) |
| Median days from peritonitis to death | 247 (64–552)b |
| Smoking status | |
| current | 145 (11.0) |
| former | 581 (44.1) |
| never | 590 (44.8) |
| Body mass index (kg/m2) | |
| <20 | 106 (8.1) |
| 20.0–24.9 | 456 (34.9) |
| 25.0–29.9 | 472 (36.1) |
| ≥30 | 273 (20.9) |
| Diabetes | 53 (4.0) |
| type I | 330 (25.1) |
| type II noninsulin requiring | 312 (23.7) |
| type II insulin requiring | |
| Other comorbidities | |
| chronic lung disease | 369 (28.0) |
| coronary artery disease | 1029 (78.2) |
| peripheral vascular disease | 710 (54.4) |
| cerebrovascular disease | 508 (38.6) |
| no comorbidity | 78 (5.9) |
| Membrane transport status | |
| low | 52 (4.0) |
| low average | 327 (24.8) |
| high average | 479 (36.4) |
| high | 191 (14.5) |
| unknown | 267 (20.3) |
| Kt/V (total) | 1.8 (0.6)a |
Data are presented as n (%) unless otherwise noted.
a
Mean (SD)
b
25th and 75th percentile.